Natalie Sinclair

718 total citations
18 papers, 349 citations indexed

About

Natalie Sinclair is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Natalie Sinclair has authored 18 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Natalie Sinclair's work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (4 papers). Natalie Sinclair is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (4 papers). Natalie Sinclair collaborates with scholars based in United States, United Kingdom and Italy. Natalie Sinclair's co-authors include Timothy C. Wang, Theodore J. Koh, Hyman B. Muss, Berta M. Geller, Benjamin Littenberg, Sara M. Tolaney, Graham J. Dockray, Alfred N. Van Hoek, Elizabeth A. Mittendorf and Duan Chen and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Natalie Sinclair

15 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie Sinclair United States	9	231	84	71	69	66	18	349
Ozlen Saglam United States	14	189 0.8×	51 0.6×	89 1.3×	126 1.8×	61 0.9×	26	411
Giovanna Bosshard Switzerland	11	128 0.6×	96 1.1×	23 0.3×	95 1.4×	61 0.9×	15	401
Patrick Tas France	10	91 0.4×	82 1.0×	129 1.8×	66 1.0×	21 0.3×	31	319
Kotaro Nomura Japan	6	152 0.7×	82 1.0×	58 0.8×	91 1.3×	109 1.7×	22	328
Norihiko Kawamura Japan	10	108 0.5×	76 0.9×	65 0.9×	255 3.7×	97 1.5×	46	429
João Magalhães Portugal	8	277 1.2×	111 1.3×	35 0.5×	231 3.3×	36 0.5×	8	747
Song-Chang Lin United States	6	120 0.5×	31 0.4×	68 1.0×	151 2.2×	82 1.2×	11	280
Maoyong Fu China	12	55 0.2×	41 0.5×	67 0.9×	161 2.3×	84 1.3×	28	349
P. Scullin United Kingdom	4	153 0.7×	31 0.4×	92 1.3×	105 1.5×	107 1.6×	7	336

Countries citing papers authored by Natalie Sinclair

Since Specialization

Citations

This map shows the geographic impact of Natalie Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Sinclair more than expected).

Fields of papers citing papers by Natalie Sinclair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Sinclair. The network helps show where Natalie Sinclair may publish in the future.

Co-authorship network of co-authors of Natalie Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Sinclair. A scholar is included among the top collaborators of Natalie Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Sinclair. Natalie Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mayer, Erica L., Sean Singer, Maria A. Stalteri, et al.. (2025). Assessing the impact of scalp cooling in patients receiving trastuzumab deruxtecan for metastatic breast cancer.. Journal of Clinical Oncology. 43(16_suppl). 1095–1095.

Mayer, Erica L., Dario Trapani, Se Eun Kim, et al.. (2025). The TRADE study: A phase 2 trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer.. Journal of Clinical Oncology. 43(16_suppl). 517–517.

Garrido-Castro, Ana C., Aparna Gorthi, Se Eun Kim, et al.. (2025). Cell-free circulating chromatin profiling for epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer.. Journal of Clinical Oncology. 43(16_suppl). 1081–1081.

Garrido-Castro, Ana C., Se Eun Kim, Rita Nanda, et al.. (2024). SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA1004–LBA1004. 20 indexed citations

Sinclair, Natalie, et al.. (2022). The taxonomy of selected marine microplankton from the Middle and Upper Jurassic (Callovian–Kimmeridgian) of the North West Shelf, Australia. Review of Palaeobotany and Palynology. 304. 104668–104668. 1 indexed citations

Waks, Adrienne G., Neelam V. Desai, Tianyu Li, et al.. (2021). Abstract PD3-05: The DAPHNE trial: A feasibility study of chemotherapy de-escalation based on response to neoadjuvant paclitaxel-HP (THP) in HER2-positive breast cancer. Cancer Research. 81(4_Supplement). PD3–5. 4 indexed citations

Tolaney, Sara M., Romualdo Barroso‐Sousa, Tanya E. Keenan, et al.. (2020). Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer. JAMA Oncology. 6(10). 1598–1598. 110 indexed citations

Tolaney, Sara M., Romualdo Barroso‐Sousa, Tanya E. Keenan, et al.. (2019). Randomized phase II study of eribulin mesylate (E) with or without pembrolizumab (P) for hormone receptor-positive (HR+) metastatic breast cancer (MBC).. Journal of Clinical Oncology. 37(15_suppl). 1004–1004. 22 indexed citations

Cheng, Huan, Yalai Bai, William M. Sikov, et al.. (2014). Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab. BMC Cancer. 14(1). 326–326. 19 indexed citations

10.

Castillo, Jorge J., Natalie Sinclair, Brady Beltrán, et al.. (2013). Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP. Leukemia Research. 37(4). 386–391. 7 indexed citations

11.

Sinclair, Natalie, Maysa Abu‐Khalaf, George Somlo, et al.. (2013). Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+ breast cancer: A BrUOG study.. Journal of Clinical Oncology. 31(15_suppl). 619–619. 6 indexed citations

12.

Sinclair, Natalie, Maysa Abu‐Khalaf, Tina Rizack, et al.. (2012). Neoadjuvant weekly nab-paclitaxel (wA), carboplatin (Cb) plus bevacizumab (B) with or without dose-dense doxorubicin-cyclophosphamide (ddAC) plus B in ER+/HER2-negative (HR+) and triple-negative (TN) breast cancer (BrCa): A BrUOG study.. Journal of Clinical Oncology. 30(15_suppl). 1045–1045. 8 indexed citations

13.

Castillo, Jorge J., Natalie Sinclair, Dariusz Stachurski, & Eric D. Jacobsen. (2011). Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: A unifying diagnosis. American Journal of Hematology. 86(8). 690–693. 3 indexed citations

14.

Sinclair, Natalie, Benjamin Littenberg, Berta M. Geller, & Hyman B. Muss. (2011). Accuracy of Screening Mammography in Older Women. American Journal of Roentgenology. 197(5). 1268–1273. 38 indexed citations

15.

Khurshid, Humera & Natalie Sinclair. (2011). Use of monoclonal antibodies in oncology.. PubMed. 94(11). 325–8, 332. 2 indexed citations

16.

McLaughlin, John, Wandong Ai, Natalie Sinclair, et al.. (2004). PACAP and gastrin regulate the histidine decarboxylase promoter via distinct mechanisms. American Journal of Physiology-Gastrointestinal and Liver Physiology. 286(1). G51–G59. 10 indexed citations

17.

Sinclair, Natalie, Wandong Ai, Raktima Raychowdhury, et al.. (2004). Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism. American Journal of Physiology-Gastrointestinal and Liver Physiology. 286(6). G992–G999. 36 indexed citations

18.

Chen, Duan, Chun‐Mei Zhao, Graham J. Dockray, et al.. (2000). Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice. Gastroenterology. 119(3). 756–765. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact